doi:10.1002/14651858.CD012990.pub2 200
These mast cell mediators provoke potent inflammatory responses that can include urticaria (AKA hives-skin rash and swelling), angioedema (swelling beneath the skin surface), bronchoconstriction (airway constriction), diarrhea, vomiting, hypotension (low blood pressure), cardiovascular collapse, and death, all within a matter of minutes
The risk associated with compounded medicines containing GLP1 agonists are posed by the absence of the evaluation of these medicines by SAHPRA and the unknown nature and safety of ingredients used in compounding
It is not approved for people with Type 1 diabetes and shouldn't be taken in women who are pregnant or breastfeeding and it is ill-advised at the moment to be using it in children
Activation of TLR3 by EBERs or of TLR2 by EBV dUTPases results in the release of proinflammatory cytokines (IL-1, IL-6, IL-8, IL-12, TNF-, and IFN-) and IL-10